• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬皮病的组织病理学皮肤改变:一项临床病理学研究。

Histopathological cutaneous alterations in systemic sclerosis: a clinicopathological study.

机构信息

Department of Rheumatology, Ghent University Hospital, De Pintelaan 185, BE-9000 Gent, Belgium.

出版信息

Arthritis Res Ther. 2011 Feb 28;13(1):R35. doi: 10.1186/ar3267.

DOI:10.1186/ar3267
PMID:21356083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3241379/
Abstract

INTRODUCTION

The aims of the present study were to identify histopathological parameters which are linked to local clinical skin disease at two distinct anatomical sites in systemic sclerosis (SSc) patients with skin involvement (limited cutaneous systemic sclerosis (lcSSc) or diffuse cutaneous systemic sclerosis (dcSSc)) and to determine the sensitivity of SSc specific histological alterations, focusing on SSc patients without clinical skin involvement (limited SSc (lSSc)).

METHODS

Histopathological alterations were systematically scored in skin biopsies of 53 consecutive SSc patients (dorsal forearm and upper inner arm) and 18 controls (upper inner arm). Clinical skin involvement was evaluated using the modified Rodnan skin score. In patients with lcSSc or dcSSc, associations of histopathological parameters with local clinical skin involvement were determined by generalised estimation equation modelling.

RESULTS

The hyalinised collagen score, the myofibroblast score, the mean epidermal thickness, the mononuclear cellular infiltration and the frequency of focal exocytosis differed significantly between biopsies with and without local clinical skin involvement. Except for mononuclear cellular infiltration, all of the continuous parameters correlated with the local clinical skin score at the dorsal forearm. Parakeratosis, myofibroblasts and intima proliferation were present in a minority of the SSc biopsies, but not in controls. No differences were found between lSSc and controls.

CONCLUSIONS

Several histopathological parameters are linked to local clinical skin disease. SSc-specific histological alterations have a low diagnostic sensitivity.

摘要

简介

本研究旨在确定与系统性硬化症(SSc)患者皮肤受累(局限性皮肤型 SSc(lcSSc)或弥漫性皮肤型 SSc(dcSSc))两个不同解剖部位的局部临床皮肤疾病相关的组织病理学参数,并确定 SSc 特异性组织学改变的敏感性,重点关注无临床皮肤受累的 SSc 患者(局限性 SSc(lSSc))。

方法

对 53 例连续 SSc 患者(前臂背侧和上臂内侧)和 18 例对照者(上臂内侧)的皮肤活检标本进行组织病理学改变的系统评分。采用改良 Rodnan 皮肤评分评估皮肤受累的临床情况。在 lcSSc 或 dcSSc 患者中,采用广义估计方程模型确定组织病理学参数与局部临床皮肤受累的相关性。

结果

有和无局部临床皮肤受累的活检标本之间的胶原纤维透明化评分、肌成纤维细胞评分、平均表皮厚度、单核细胞浸润和局灶性胞吐的频率存在显著差异。除单核细胞浸润外,所有连续参数均与前臂背侧的局部临床皮肤评分相关。角化过度、肌成纤维细胞和内膜增生在少数 SSc 活检标本中存在,但在对照组中不存在。lSSc 与对照组之间无差异。

结论

一些组织病理学参数与局部临床皮肤疾病相关。SSc 特异性组织学改变的诊断敏感性较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfdb/3241379/9e468a2116c3/ar3267-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfdb/3241379/9e468a2116c3/ar3267-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfdb/3241379/9e468a2116c3/ar3267-1.jpg

相似文献

1
Histopathological cutaneous alterations in systemic sclerosis: a clinicopathological study.系统性硬皮病的组织病理学皮肤改变:一项临床病理学研究。
Arthritis Res Ther. 2011 Feb 28;13(1):R35. doi: 10.1186/ar3267.
2
The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis.改良的罗德南皮肤评分是系统性硬化症中皮肤活检厚度的准确反映。
J Rheumatol. 1998 Jan;25(1):84-8.
3
Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta.系统性硬化症中软骨寡聚基质蛋白的表达揭示了真皮成纤维细胞对转化生长因子β反应的异质性。
Ann Rheum Dis. 2009 Mar;68(3):435-41. doi: 10.1136/ard.2007.086850. Epub 2008 Apr 13.
4
Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.抗拓扑异构酶I抗体阳性的系统性硬化症患者的临床亚组、皮肤厚度进展率及血清抗体水平
Arthritis Rheum. 2007 Aug;56(8):2740-6. doi: 10.1002/art.22747.
5
Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis.皮肤周围神经系统的损伤根据系统性硬化症的疾病阶段和亚型而有不同的演变。
Rheumatology (Oxford). 2005 May;44(5):607-13. doi: 10.1093/rheumatology/keh559. Epub 2005 Feb 22.
6
Ultrasound assessment of skin thickness and stiffness: the correlation with histology and clinical score in systemic sclerosis.系统性硬化症中皮肤厚度和硬度的超声评估:与组织学及临床评分的相关性
Arthritis Res Ther. 2020 Aug 26;22(1):197. doi: 10.1186/s13075-020-02285-x.
7
High-throughput quantitative histology in systemic sclerosis skin disease using computer vision.基于计算机视觉的系统性硬化症皮肤疾病高通量定量组织学。
Arthritis Res Ther. 2020 Mar 14;22(1):48. doi: 10.1186/s13075-020-2127-0.
8
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database.局限性皮肤系统性硬化症患者的结局:来自 EUSTAR 数据库的超过 12000 例患者的结果。
Autoimmun Rev. 2020 Feb;19(2):102452. doi: 10.1016/j.autrev.2019.102452. Epub 2019 Dec 12.
9
Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis.系统性硬化症患者皮肤和外周血中单核细胞/巨噬细胞亚群的特征。
Arthritis Res Ther. 2010;12(4):R128. doi: 10.1186/ar3066. Epub 2010 Jul 5.
10
Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.无硬皮病的系统性硬化症:1417例受试者的多中心研究。
J Rheumatol. 2014 Nov;41(11):2179-85. doi: 10.3899/jrheum.140236. Epub 2014 Oct 1.

引用本文的文献

1
Performance of Ultra-High-Frequency Ultrasound in the Evaluation of Skin Involvement in Systemic Sclerosis: A Cross-Sectional Pilot Study.超高频率超声在系统性硬化症皮肤受累评估中的应用:一项横断面初步研究。
Diagnostics (Basel). 2025 Jun 24;15(13):1600. doi: 10.3390/diagnostics15131600.
2
Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosis.在一项针对系统性硬化症患者的贝利莫司他试验中,神经网络分析作为一种新的皮肤结局。
Arthritis Res Ther. 2025 Apr 11;27(1):85. doi: 10.1186/s13075-025-03508-9.
3
Assessment of skin fibrosis in a murine model of systemic sclerosis with multifunctional optical coherence tomography.

本文引用的文献

1
Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study.系统性硬化症队列中定性和半定量甲襞毛细血管显微镜评估的可靠性:一项双中心研究。
Ann Rheum Dis. 2010 Jun;69(6):1092-6. doi: 10.1136/ard.2009.115568. Epub 2010 May 3.
2
Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis.皮肤慢性移植物抗宿主病不具有系统性硬化症的异常内皮细胞表型或血管稀疏特征。
PLoS One. 2009 Jul 9;4(7):e6203. doi: 10.1371/journal.pone.0006203.
3
Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study.
利用多功能光学相干断层扫描技术评估系统性硬化症小鼠模型中的皮肤纤维化情况。
J Biomed Opt. 2025 Mar;30(3):036007. doi: 10.1117/1.JBO.30.3.036007. Epub 2025 Mar 27.
4
Disturbed Spatial WNT Activation-A Potential Driver of the Reticularized Skin Phenotype in Systemic Sclerosis.空间WNT激活紊乱——系统性硬化症中网状皮肤表型的潜在驱动因素
Arthritis Rheumatol. 2025 Jun;77(6):740-749. doi: 10.1002/art.43094. Epub 2025 Mar 11.
5
Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of Systemic Sclerosis (VEDOSS).系统性硬化症极早期诊断(VEDOSS)患者的皮肤和血清中存在系统性硬化症的生物学特征。
Rheumatology (Oxford). 2025 Jun 1;64(6):3606-3617. doi: 10.1093/rheumatology/keae698.
6
Wound healing: insights into autoimmunity, ageing, and cancer ecosystems through inflammation and IL-6 modulation.伤口愈合:通过炎症和白细胞介素-6调节深入了解自身免疫、衰老和癌症生态系统。
Front Immunol. 2024 Nov 29;15:1403570. doi: 10.3389/fimmu.2024.1403570. eCollection 2024.
7
Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosis.在一项针对系统性硬化症患者的贝利莫司他试验中,神经网络分析作为一种新的皮肤结局。
Res Sq. 2024 Oct 15:rs.3.rs-4889334. doi: 10.21203/rs.3.rs-4889334/v1.
8
Spatial Transcriptomics Identifies Cellular and Molecular Characteristics of Scleroderma Skin Lesions: Pilot Study in Juvenile Scleroderma.空间转录组学鉴定硬皮病皮肤损伤的细胞和分子特征:青少年硬皮病的初步研究。
Int J Mol Sci. 2024 Aug 23;25(17):9182. doi: 10.3390/ijms25179182.
9
[Systemic sclerosis].[系统性硬化症]
Dermatologie (Heidelb). 2024 Mar;75(3):181-196. doi: 10.1007/s00105-024-05298-8. Epub 2024 Feb 16.
10
Treatment of Scleroderma-Related Microstomia Using Hyaluronic Acid: An Interventional Study.透明质酸治疗硬皮病相关小口畸形的干预性研究。
Life (Basel). 2023 Nov 7;13(11):2176. doi: 10.3390/life13112176.
利妥昔单抗治疗弥漫性皮肤系统性硬化症:一项开放性临床和组织病理学研究。
Ann Rheum Dis. 2010 Jan;69(1):193-7. doi: 10.1136/ard.2008.095463.
4
Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.自身抗体和微血管损伤是雷诺现象进展为系统性硬化症的独立预测因素:一项对586例患者的20年前瞻性研究,并对早期系统性硬化症的拟议标准进行了验证。
Arthritis Rheum. 2008 Dec;58(12):3902-12. doi: 10.1002/art.24038.
5
Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer.硬皮病皮损皮肤的蛋白质组学分析揭示了表皮细胞层的活化伤口愈合表型。
Rheumatology (Oxford). 2008 Dec;47(12):1754-60. doi: 10.1093/rheumatology/ken370. Epub 2008 Oct 1.
6
Scleroderma-like fibrosing disorders.硬皮病样纤维化疾病
Rheum Dis Clin North Am. 2008 Feb;34(1):199-220; ix. doi: 10.1016/j.rdc.2007.11.001.
7
Systemic sclerosis - continuing progress in developing clinical measures of response.系统性硬化症——在制定临床反应测量方法方面不断取得进展。
J Rheumatol. 2007 May;34(5):1194-200.
8
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.高剂量免疫抑制疗法及自体造血细胞移植治疗重症系统性硬化症:美国多中心试点研究的长期随访
Blood. 2007 Aug 15;110(4):1388-96. doi: 10.1182/blood-2007-02-072389. Epub 2007 Apr 23.
9
Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis.肌成纤维细胞和玻璃样变性胶原蛋白作为系统性硬化症皮肤病变的标志物。
Arthritis Rheum. 2006 Nov;54(11):3655-60. doi: 10.1002/art.22186.
10
Mechanisms and consequences of fibrosis in systemic sclerosis.系统性硬化症中纤维化的机制及后果
Nat Clin Pract Rheumatol. 2006 Mar;2(3):134-44. doi: 10.1038/ncprheum0115.